CHEN Liangshan. Analysis on distribution of pathogenic bacteria and drug sensitivity in patients with urogenital tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 66-69. DOI: 10.7619/jcmp.202022019
Citation: CHEN Liangshan. Analysis on distribution of pathogenic bacteria and drug sensitivity in patients with urogenital tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 66-69. DOI: 10.7619/jcmp.202022019

Analysis on distribution of pathogenic bacteria and drug sensitivity in patients with urogenital tract infection

More Information
  • Received Date: September 24, 2020
  • Available Online: December 21, 2020
  • Published Date: December 02, 2020
  • Objective To observe the distribution of pathogenic bacteria and drug sensitivity of patients with urogenital tract infection. Methods A total of 600 patients with urogenital tract infection were selected as study subjects, and urethral discharge of male patients and cervical secretions of female patients were collected, pathogen culture and drug sensitivity test were conducted in a sterile environment, the distribution of pathogenic bacteria and drug resistance were observed and analyzed. Results A total of 1 562 strains of pathogenic bacteria were isolated from 600 patients with urogenital tract infection, including 1 103 strains of Mycoplasma and 459 strains. Ureaplasma urealyticum(Uu)and Mycoplasma hominis(Mh)were main Mycoplasma infection, accounting for 33.03%(516/1 562)and 14.40%(225/1 562), respectively; Enterobacteriaceae and Enterococcus were the main bacteria, accounting for 11.65%(182/1 562)and 8.58%(134/1 562), respectively. The susceptibilities test showed that Uu and Mh were highly sensitive to josamycin, doxycycline, and minocycline, while their sensitivities to erythromycin and ofloxacin were low. Enterobacteriaceae was highly sensitive to imipenem, meroppenem, piperacillin/tazobactam, while was lowly sensitive to amoxicillin and ticacillin. Enterococcus was highly sensitive to vancomycin and tekoranin, while was lowly sensitive to erythromycin. Conclusion Mycoplasma infection is the main infection source in patients with urogenital tract infection, and bacteria infection is also presented. Therefore, clinical trials should be strengthened the susceptibility results of pathogenic bacteria in infected patients, so as to reasonably select antibacterial drugs.
  • 王海燕. 2013—2015年天津市武清区中医医院女性泌尿生殖道感染的病原菌分布及耐药性分析[J]. 现代药物与临床, 2016, 31(8): 1296-1299.
    冯登礼, 王瑗, 葛敏. 2016—2017年连云港市妇幼保健院女性泌尿生殖道感染的病原菌分布及耐药性分析[J]. 现代药物与临床, 2018, 33(11): 3060-3063.
    李仕伟, 傅雷, 刘艳秋, 等. 泌尿生殖道支原体感染及耐药性分析[J]. 现代预防医学, 2015, 42(4): 762-763.
    HORNER P, DONDERS G, CUSINI M, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women- a position statement from the European STI Guidelines Editorial Board[J]. J Eur Acad Dermatol Venereol, 2018, 32(11): 1845-1851.
    裴显峰. 女性泌尿生殖道感染患者衣原体检测支原体培养及药敏分析[J]. 当代医学, 2016, 22(11): 63-64.
    晋兴, 武爱荣, 黄波, 等. 用纸片扩散法和微量稀释法进行药物敏感性测定的比较[J]. 国际检验医学杂志, 2014, 35(3): 322-324.
    张雅薇, 王辉. 2015年CLSI M100-S25主要更新内容介绍[J]. 中华检验医学杂志, 2015, 38(4): 229-232.
    MIYAKE M, OHNISHI K, HORI S, et al. Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens[J]. Cells, 2019, 8(3): 212-215.
    胡森安, 艾红红, 吴惠强, 等. 1708例泌尿生殖道支原体感染检测及药敏分析[J]. 国际检验医学杂志, 2017, 38(4): 530-532.
    DEBORDE M, PEREYRE S, PUGES M, et al. High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program[J]. Med Mal Infect, 2019, 49(5): 347-349.
    潘长清, 王丹, 邓艳梅, 等. 2014—2016年绵阳市中心医院女性泌尿生殖道感染的病原菌分布及耐药性分析[J]. 现代药物与临床, 2016, 31(9): 1505-1508.
    JENSEN JS, CUSINI M, GOMBERG M, et al. 2016 European guideline on Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2016, 30(10): 1650-1656.
    龚娅, 段德令, 何宗忠, 等. 19530例泌尿生殖道感染患者支原体感染及药敏结果分析[J]. 重庆医学, 2015, 44(25): 3539-3541.
    王鹏, 泰淑红, 邵艳, 等. 泌尿生殖道支原体感染状况及药敏结果分析[J]. 实用检验医师杂志, 2015, 7(2): 100-103.
    丁玲加提, 姚楠, 邵惠. 新疆克拉玛依地区泌尿生殖道支原体感染的病原分型及药敏分析[J]. 实用皮肤病学杂志, 2015, 8(5): 357-359.
    杨时瀚, 罗育豪, 蔡锦楠, 等. 广东潮汕地区3785例泌尿生殖道感染患者支原体分布及药敏分析[J]. 临床皮肤科杂志, 2019, 48(11): 659-661.
    石月萍, 周海燕, 王国英. 女性泌尿生殖道支原体、衣原体及淋球菌感染的结果分析[J]. 中国卫生检验杂志, 2019, 29(20): 2517-2519

    , 2523.
    邓佳, 陈君, 周颖, 等. 性病门诊泌尿生殖道感染者病原菌检测及药敏分析[J]. 中华男科学杂志, 2019, 25(10): 950-952.
  • Related Articles

    [1]CHEN Gong, SUN Chao, CHAI Haina, WU Yingying, WANG Lu, CHEN Chaowu, TANG Dong, LIU Jun. Application of endoscopic mucosal ligation resection in rectal neuroendocrine tumors[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 21-25. DOI: 10.7619/jcmp.20221529
    [2]YIN Bo, ZHAO Yinying, QING Chu. Value of percutaneous lung puncture and biopsy combined with detection of tumor markers in diagnosis of pulmonary occupying lesions[J]. Journal of Clinical Medicine in Practice, 2020, 24(24): 6-9. DOI: 10.7619/jcmp.202024002
    [3]ZHAO Tongsheng, ZHOU Guangchen, LIU Changkun. Analysis on the curative efficacy of bladder tumor endoscopic submucosal dissection in the treatment of non-muscle invasive bladder cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 28-31. DOI: 10.7619/jcmp.202011008
    [4]WANG Chengxiu, ZHANG Liping. Effect of transvaginal excision of pregnancy lesion in cesarean scar and hysteroplasty in the treatment of cesarean scar pregnancy[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 84-86. DOI: 10.7619/jcmp.201918024
    [5]HUO Chunyan, HAN Huifang, WU Min. Nursing of endoscopic submucosal dissection in the diagnosis and treatment of gastrointestinal mucosal lesions[J]. Journal of Clinical Medicine in Practice, 2018, (12): 78-80. DOI: 10.7619/jcmp.201812023
    [6]GUO Qi, WANG Ping. Perioperative nursing for endoscopic resection of duodenal papillary tumor patients[J]. Journal of Clinical Medicine in Practice, 2017, (10): 60-62. DOI: 10.7619/jcmp.201710019
    [7]ZHU Sheng. Effects of different liquid pads in reducing risk of complication after colorectal polypendoscopic mucosal resection[J]. Journal of Clinical Medicine in Practice, 2015, (Z1): 120-122.
    [8]SHI Lei, CHEN Ping, ZHU Haihang, ZHAO Wei, WANG Hao, CHEN Di, CHEN Fu. Application of endoscopic submucosal dissection and its derivative technology in treatment of patients with gastric submucosal tumor[J]. Journal of Clinical Medicine in Practice, 2015, (3): 57-59. DOI: 10.7619/jcmp.201503016
    [9]ZHANG Ming, SHEN Hongzhang. Clinical analysis of gastro-endoscopic mucosal resection in treating 40 patients with sub-mucosal tumors in esophagus[J]. Journal of Clinical Medicine in Practice, 2013, (21): 91-93. DOI: 10.7619/jcmp.201321025
    [10]ZHU Xiaolei, CHEN Zhitan. Analysis of endoscopic mucosal resection and endoscopic submucosal dissection for gastrointestinal elevated lesions[J]. Journal of Clinical Medicine in Practice, 2012, (24): 40-42.
  • Cited by

    Periodical cited type(10)

    1. 廖倩. 5A护理模式在激素冲击治疗胸腰椎骨折伴脊髓损伤患者中的应用效果. 中国药物经济学. 2024(S1): 188-189+192 .
    2. 杨莹娟,刘晓曦,刘春枝. 5A护理模式在激素冲击治疗胸腰椎骨折伴脊髓损伤患者期间的应用效果. 中国药物滥用防治杂志. 2023(02): 352-355 .
    3. 孙常磊. ACTED康复模式在下肢骨折患者术后肢体康复护理中的应用. 国际护理学杂志. 2023(15): 2812-2815 .
    4. 阳凡,何曦,方清,陈霞. 基于循证理念的血栓防治小组对骨折术后卧床患者深静脉血栓发生率的影响. 临床医药实践. 2023(10): 782-785 .
    5. 顾光丽,胡丽华,张菱,孙丽华. 椎体压缩性骨折患者行经皮椎体成型术后的疗效及心理护理. 吉林医学. 2022(07): 1995-1997 .
    6. 刘俊梅. 经皮椎体成形术治疗脊椎压缩性骨折围术期护理体会. 基层医学论坛. 2022(27): 42-44 .
    7. 周宣业,孙苏亭,高峰. 股骨颈骨折患者围手术期深静脉血栓发生现状及危险因素分析. 临床医学研究与实践. 2022(30): 20-23+36 .
    8. 叶钱琳. 早期康复护理结合多元化健康教育对老年胸腰椎压缩性骨折手术患者自护能力、康复效果的影响. 名医. 2022(23): 129-131 .
    9. 谢瑶,侯慧芳. 预见性护理结合预警评分预防骨折患者静脉血栓栓塞症发生的效果. 临床医学研究与实践. 2021(13): 156-158 .
    10. 卢慧简,麦华玉. “5A”护理预防长期卧床呼吸衰竭患者DVT发生的效果. 中国卫生标准管理. 2021(12): 143-146 .

    Other cited types(0)

Catalog

    Article views (382) PDF downloads (16) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return